SOLESENCE, INC.
Company Background On March 7, 2025, Nanophase Technologies Corporation announced its rebranding as Sol sence, Inc. ( Sol sence, Company, we, our, or us ), marking a new chapter in its commitment to s…
Company Background On March 7, 2025, Nanophase Technologies Corporation announced its rebranding as Sol sence, Inc. ( Sol sence, Company, we, our, or us ), marking a new chapter in its commitment to skin health innovation and consumer products across beauty, health, and wellness categories. Our corporate website has transitioned to solesence.com and investor relations information, including historical Nanophase financials and disclosures, is available at ir.solesence.com. Nanophase Technologies Corporation changed its legal name to Sol sence, Inc. by amending its certificate of incorporation with the State of Delaware on March 10, 2025 and by filing a certificate of correction on June 3, 2025. Sol sence, along with its wholly owned subsidiary, Sol sence, LLC (our Sol sence consumer products subsidiary ), is a leading innovator in scientifically driven health care solutions across beauty, health and wellness categories, protecting skin from environmental aggressors and enhancing the aesthetic appeal of health-enhancing products. Skin health, addressed through both our Consumer Products and our Active Pharmaceutical Ingredients ( APIs ), currently make up the great majority of our business, with additional revenue being generated from other legacy advanced materials applications. The Company was incorporated in Illinois on November 25, 1989, and became a Delaware corporation during November 1997. Our common stock trades on NASDAQ under the symbol SLSN. We have development and testing laboratories, and manufacturing capability in two locations in the Chicago, Illinois area.
Run a full DCF model with Monte Carlo simulation.